Home / Companies / Iovance Biotherapeutics, Inc. / 11 Jun 2024
Iovance Biotherapeutics, Inc.: meeting of 11 Jun 2024
Votes reported on Form N-PX, item by item
371 Form N-PX filers reported votes at the Iovance Biotherapeutics, Inc. meeting of 11 Jun 2024. Their records fall into 5 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
7 nominees; 92.0% of reported votes for; 52 filers withheld from or voted against at least one nominee.
1,464 vote records from 116 filers. 0 of the 115 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
One filer reported a share count too large to be the holding described. That figure is left out of the share split below; the count of filers includes it. How that is decided
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on executive pay (say-on-pay)
516 vote records from 368 filers. 37 of the 348 filers that marked the item either way voted against management. 20 filers reported this item without a management mark.
One filer reported a share count too large to be the holding described. That figure is left out of the share split below; the count of filers includes it. How that is decided
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
209 vote records from 115 filers. 0 of the 114 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
One filer reported a share count too large to be the holding described. That figure is left out of the share split below; the count of filers includes it. How that is decided
CAPITAL STRUCTUREIssuer
CAPITAL STRUCTURE: management items
Management items in this category are shown together; filers word and number them differently.
24 vote records from 18 filers. 0 of the 18 filers that marked the item either way voted against management.
COMPENSATIONIssuer
COMPENSATION: management items
Management items in this category are shown together; filers word and number them differently.
402 vote records from 118 filers. 0 of the 117 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
One filer reported a share count too large to be the holding described. That figure is left out of the share split below; the count of filers includes it. How that is decided
How the largest families voted
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Iovance Biotherapeutics, Inc. meeting?
371 Form N-PX filers reported votes at the meeting of 11 Jun 2024. On say-on-pay, 37 of 348 voted against management (10.6%). The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Iovance Biotherapeutics, Inc. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Iovance Biotherapeutics, Inc.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Iovance Biotherapeutics, Inc. with a meeting date within three days of 11 Jun 2024. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.